Search

IAS-USA guidelines now support cabotegravir / rilpivirine in this population

Showing "11154" results for ""

Nearly two million people in sub-Saharan Africa may have advanced HIV disease

Should event-driven PrEP be an option for women?

Top 5 stories on co-morbidities affecting people with HIV from CROI 2024

Long-acting injectables can be a good option for people with adherence challenges

Top 5 HIV PrEP stories from CROI 2024

Top 5 stories on HIV and women from CROI 2024

Over 30 years, big fall in HIV among people who inject drugs in Baltimore, but hepatitis C remains high

Top 5 stories on injectable HIV treatment and PrEP from CROI 2024

People who inject drugs in the US are more aware of PrEP, but aren’t taking it

Top 5 stories on HIV in the US from CROI 2024

Almost two-thirds of new HIV cases occur outside southern and eastern Africa

Adolescents prefer long-acting injectables to daily oral HIV treatment, study finds

The US opioid crisis has reached older people with HIV

Weight gain on HIV treatment: more than a 'return to health' phenomenon?

Why is the roll-out of injectable PrEP taking so long?

Nigerian analysis defines what makes a youth-friendly HIV service work

Big falls in HIV deaths in high-income countries – except for injecting drug users

HIV clinicians in Spain underestimate their patients’ HIV-related symptoms

Receive the latest HIV research and conference news

Showing "11154" results for ""

Nearly two million people in sub-Saharan Africa may have advanced HIV disease

Should event-driven PrEP be an option for women?

Top 5 stories on co-morbidities affecting people with HIV from CROI 2024

Long-acting injectables can be a good option for people with adherence challenges

Top 5 HIV PrEP stories from CROI 2024

Top 5 stories on HIV and women from CROI 2024

Over 30 years, big fall in HIV among people who inject drugs in Baltimore, but hepatitis C remains high

Top 5 stories on injectable HIV treatment and PrEP from CROI 2024

People who inject drugs in the US are more aware of PrEP, but aren’t taking it

Top 5 stories on HIV in the US from CROI 2024

Almost two-thirds of new HIV cases occur outside southern and eastern Africa

Adolescents prefer long-acting injectables to daily oral HIV treatment, study finds

The US opioid crisis has reached older people with HIV

Weight gain on HIV treatment: more than a 'return to health' phenomenon?

Why is the roll-out of injectable PrEP taking so long?

Nigerian analysis defines what makes a youth-friendly HIV service work

Big falls in HIV deaths in high-income countries – except for injecting drug users

HIV clinicians in Spain underestimate their patients’ HIV-related symptoms

Receive the latest HIV research and conference news